Loading
VP
ValiRx PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest was filed 04 Mar 2026.
ValiRx PLC: what insiders have been doing
ValiRx PLC has a thin disclosure history in our data (latest filing: 4 March 2026). New filings will appear here as soon as they are published. These figures are compiled from regulatory filings published by RNS (LSE). They describe what insiders did and are not a recommendation.
Insider Decl.
1
Thresholds
n/a
Buy Volume
€3,783
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleMark Eccleston1 buy
Since the insiders bought
- -44.8%Entry £0.00 · Close at T+90 £0.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 24,128 of 24,148 companies
2.2
score / 100
Value2
Quality3
FCF yld-77%
Earn yld-113%
EV/EBITDA·
ROE-77%
Gross mgn-20%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
£0.00
Analyst consensus
Income statement
Revenue£31.4k
Gross profit-£6.3k-20% margin
EBITDA-£2.2M-6939% margin
Net income-£2.2M-7115.1% margin
Valuation
P/Book37.5x
Beta-0.24
Balance sheet & cash
Market cap£2M
Total debt£1.4k
Free Cash Flow-£1.5M
Debt / Equity0%
Profitability & ownership
ROE-77.3%
ROA-36.4%
% insiders8.8%
% institutions0.0%
Last declaration on 4 March 2026
Declarations1 total
1,000,000 shares@ £0.0033100.0% of flowAIMISIN GB00BLH13C52RNS:f9bc483b-55f9-40c1-b450-a5f26414184a
Canonical exit: 1 Jun 2026 (T+90)
1 of 1 declaration
About ValiRx PLC
ValiRx PLC is a biopharmaceutical company focused on developing treatments for cancer and other diseases. It is listed on the London Stock Exchange.
